By Kate Hammeke, VP of Market Research, Industry Standard Research (ISR) @ISRreports
In the past 50 years, since the onset of the digital age, the world has been transformed by technology. In the last decade, we’ve seen technology further disrupt the way we shop, communicate, and get from point A to point B. Today, technology has the potential to transform the way the biopharmaceutical industry conducts clinical trials and even disrupt clinical development altogether. Mobile health technologies, or mHealth, have gotten a lot of buzz lately and enable patients to collect and remotely transfer health information. Examples of mHealth include a wide range of tools from health-oriented apps to activity trackers, sensors, smart watches, and beyond. In fact, many of these gadgets blur the line between cool tech and medical device, like the Series 4 Apple watch that has been given clearance by the FDA for its electrocardiogram readings.